139 related articles for article (PubMed ID: 9650552)
1. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies.
Dalerba P; Ricci A; Russo V; Rigatti D; Nicotra MR; Mottolese M; Bordignon C; Natali PG; Traversari C
Int J Cancer; 1998 Jul; 77(2):200-4. PubMed ID: 9650552
[TBL] [Abstract][Full Text] [Related]
2. MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas.
Dalerba P; Frascella E; Macino B; Mandruzzato S; Zambon A; Rosolen A; Carli M; Ninfo V; Zanovello P
Int J Cancer; 2001 Jul; 93(1):85-90. PubMed ID: 11391626
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
Zhang S; Zhou X; Yu H; Yu Y
BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
5. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.
Cormier JN; Abati A; Fetsch P; Hijazi YM; Rosenberg SA; Marincola FM; Topalian SL
J Immunother; 1998 Jan; 21(1):27-31. PubMed ID: 9456433
[TBL] [Abstract][Full Text] [Related]
7. Expression of melanoma-associated antigens in melanoma cell cultures.
Urosevic M; Braun B; Willers J; Burg G; Dummer R
Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
[TBL] [Abstract][Full Text] [Related]
8. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
9. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
[TBL] [Abstract][Full Text] [Related]
10. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M
Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302
[TBL] [Abstract][Full Text] [Related]
11. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.
Van den Eynde B; Peeters O; De Backer O; Gaugler B; Lucas S; Boon T
J Exp Med; 1995 Sep; 182(3):689-98. PubMed ID: 7544395
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
13. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
[TBL] [Abstract][Full Text] [Related]
14. Expression of A, G and B melanoma antigen genes in human hepatocellular carcinoma.
Chen Z; Shao JB; Wu W
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):570-3. PubMed ID: 14607688
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of MART-1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients.
Enk CD; Lotem M; Gimon Z; Hochberg M
Melanoma Res; 2004 Oct; 14(5):361-5. PubMed ID: 15457091
[TBL] [Abstract][Full Text] [Related]
16. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
17. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
18. MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia.
Zambon A; Mandruzzato S; Parenti A; Macino B; Dalerba P; Ruol A; Merigliano S; Zaninotto G; Zanovello P
Cancer; 2001 May; 91(10):1882-8. PubMed ID: 11346870
[TBL] [Abstract][Full Text] [Related]
19. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
Jäger E; Ringhoffer M; Altmannsberger M; Arand M; Karbach J; Jäger D; Oesch F; Knuth A
Int J Cancer; 1997 Apr; 71(2):142-7. PubMed ID: 9139833
[TBL] [Abstract][Full Text] [Related]
20. MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.
Gillespie AM; Rodgers S; Wilson AP; Tidy J; Rees RC; Coleman RE; Murray AK
Br J Cancer; 1998 Sep; 78(6):816-21. PubMed ID: 9743307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
